thrombotic thrombocytopenic purpura
Showing 1 - 24 of 24
Thrombotic Thrombocytopenic Purpura Trial in Japan (Caplacizumab (ALX-0081), Plasma exchange (PE), Corticosteroid treatment
Completed
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab (ALX-0081)
- +3 more
-
Iruma-Gun, Japan
- +11 more
Jan 30, 2023
Hereditary Thrombotic Thrombocytopenic Purpura
Recruiting
- Thrombotic Thrombocytopenic Purpura
- +4 more
- Observation
-
Oklahoma City, Oklahoma
- +6 more
Nov 1, 2022
Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Aspirin tablet
- Placebo
- (no location specified)
Sep 30, 2022
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
Recruiting
- Thrombotic Thrombocytopenic Purpura
-
Mainz, GermanyUniversity Hospital Mainz, Hematology
May 20, 2022
Thrombotic Thrombocytopenic Purpura Trial in Paris (Sulfate, Magnesium, Placebo - Concentrate)
Active, not recruiting
- Thrombotic Thrombocytopenic Purpura
- Sulfate, Magnesium
- Placebo - Concentrate
-
Paris, FranceSaint Louis hospital
Oct 28, 2021
Thrombotic Thrombocytopenic Purpura Trial in United States (rituximab)
Completed
- Thrombotic Thrombocytopenic Purpura
- rituximab
-
Atlanta, Georgia
- +3 more
Aug 13, 2021
The ConNeCT Study: Neurological Complications of TTP
Recruiting
- Thrombotic Thrombocytopenic Purpura
- Questionnaires (including PHQ-9, TYM and SF-36)
-
Liverpool, United KingdomRoyal Liverpool University Hospital
Aug 2, 2021
Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura Trial in Monterrey (Romiplostim, Rituximab, Dexamethasone)
Unknown status
- Immune Thrombocytopenia
- Thrombotic Thrombocytopenic Purpura
- Romiplostim
- +2 more
-
Monterrey, Nuevo León, MexicoServicio de Hematología, Hospital Universitario "Dr. José Eleute
Oct 8, 2020
Octaplas Adult TTP Trial
Terminated
- Thrombotic Thrombocytopenic Purpura
- Octaplas
- Standard Plasma
-
Manhasset, New York
- +1 more
Oct 10, 2019
Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura Trial in Paris (Biological and imaging investigations)
Completed
- Thrombotic Microangiopathies
- Thrombotic Thrombocytopenic Purpura
- Biological and imaging investigations
-
Paris, FranceSaint Antoine
Jul 23, 2019
The Role of Microparticles as a Biomarker
Withdrawn
- Atypical Hemolytic Uremic Syndrome
- +3 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Feb 15, 2019
Thrombotic Thrombocytopenic Purpura Trial in New York (Danazol)
Terminated
- Thrombotic Thrombocytopenic Purpura
-
New York, New YorkMount Sinai St. Luke's-Roosevelt
Dec 6, 2018
TTP and aHUS in Complicated Pregnancies
Unknown status
- Thrombotic Thrombocytopenic Purpura
- +7 more
- ADAMTS 13, complement and angiogenic biomarkers
-
London, United KingdomUniversity College London Hospital
Sep 21, 2018
Thrombotic Thrombocytopenic Purpura Trial in Columbus (Cyclosporine, Prednisone)
Completed
- Thrombotic Thrombocytopenic Purpura
-
Columbus, OhioOhio State University
Sep 20, 2017
Thrombotic Thrombocytopenic Purpura Trial in Paris (rituximab)
Completed
- Thrombotic Thrombocytopenic Purpura
-
Paris, FranceSaint-Antoine Hospital, Hematology
Feb 26, 2014
Thrombotic Thrombocytopenic Purpura Trial in United States (Rituximab, Plasma exchange, Corticosteroids)
Terminated
- Thrombotic Thrombocytopenic Purpura
- Rituximab
- +2 more
-
Birmingham, Alabama
- +22 more
Jul 18, 2013
Biorepository for TMA(Thrombotic Microangiopathy)
Terminated
- Thrombotic Microangiopathy
- +2 more
-
New Hyde Park, New YorkSchneider Chldren's Hospital
Jun 18, 2013
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
Completed
- Thrombotic Thrombocytopenic Purpura
-
Clamart, FranceHôpital Antoine Béclère
Dec 11, 2012
Thrombotic Thrombocytopenic Purpura Trial in New York (Rituximab)
Withdrawn
- Thrombotic Thrombocytopenic Purpura
-
New York, New YorkWeill Medical College of Cornell University/New York Presbyteria
Nov 14, 2012
Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome Trial in Canada (Rituximab)
Unknown status
- Thrombotic Thrombocytopenic Purpura
- Hemolytic Uremic Syndrome
-
Calgary, Alberta, Canada
- +10 more
May 18, 2010
Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura Trial in Worldwide (ARC 1779 Placebo, ARC1779 Injection)
Terminated
- Thrombotic Microangiopathy
- Thrombotic Thrombocytopenic Purpura
- ARC 1779 Placebo
- ARC1779 Injection
-
Chicago, Illinois
- +16 more
Nov 24, 2009